Cargando…
Tackling COVID-19 with neutralizing monoclonal antibodies
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Inc.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8375150/ https://www.ncbi.nlm.nih.gov/pubmed/34416148 http://dx.doi.org/10.1016/j.cell.2021.07.027 |
| _version_ | 1783740262950895616 |
|---|---|
| author | Corti, Davide Purcell, Lisa A. Snell, Gyorgy Veesler, David |
| author_facet | Corti, Davide Purcell, Lisa A. Snell, Gyorgy Veesler, David |
| author_sort | Corti, Davide |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8375150 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Elsevier Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-83751502021-08-19 Tackling COVID-19 with neutralizing monoclonal antibodies Corti, Davide Purcell, Lisa A. Snell, Gyorgy Veesler, David Cell Correction Elsevier Inc. 2021-08-19 2021-08-19 /pmc/articles/PMC8375150/ /pubmed/34416148 http://dx.doi.org/10.1016/j.cell.2021.07.027 Text en © 2021 Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Correction Corti, Davide Purcell, Lisa A. Snell, Gyorgy Veesler, David Tackling COVID-19 with neutralizing monoclonal antibodies |
| title | Tackling COVID-19 with neutralizing monoclonal antibodies |
| title_full | Tackling COVID-19 with neutralizing monoclonal antibodies |
| title_fullStr | Tackling COVID-19 with neutralizing monoclonal antibodies |
| title_full_unstemmed | Tackling COVID-19 with neutralizing monoclonal antibodies |
| title_short | Tackling COVID-19 with neutralizing monoclonal antibodies |
| title_sort | tackling covid-19 with neutralizing monoclonal antibodies |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8375150/ https://www.ncbi.nlm.nih.gov/pubmed/34416148 http://dx.doi.org/10.1016/j.cell.2021.07.027 |
| work_keys_str_mv | AT cortidavide tacklingcovid19withneutralizingmonoclonalantibodies AT purcelllisaa tacklingcovid19withneutralizingmonoclonalantibodies AT snellgyorgy tacklingcovid19withneutralizingmonoclonalantibodies AT veeslerdavid tacklingcovid19withneutralizingmonoclonalantibodies |